CINECA IRIS Institutional Research Information System

SAPONARO, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 826
NA - Nord America 601
EU - Europa 165
SA - Sud America 139
AF - Africa 26
Totale 1.757
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 563
SG - Singapore 281
CN - Cina 195
VN - Vietnam 124
BR - Brasile 102
HK - Hong Kong 90
IT - Italia 45
JP - Giappone 34
GB - Regno Unito 29
IN - India 29
DE - Germania 21
FR - Francia 20
AR - Argentina 14
BD - Bangladesh 13
MX - Messico 13
IQ - Iraq 12
ZA - Sudafrica 11
CA - Canada 10
FI - Finlandia 10
NL - Olanda 9
EC - Ecuador 8
ID - Indonesia 6
PL - Polonia 6
TR - Turchia 6
PK - Pakistan 5
SE - Svezia 5
BB - Barbados 4
JM - Giamaica 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
CL - Cile 3
ES - Italia 3
MA - Marocco 3
RU - Federazione Russa 3
TT - Trinidad e Tobago 3
UA - Ucraina 3
UZ - Uzbekistan 3
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
JO - Giordania 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
NG - Nigeria 2
PE - Perù 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
BT - Bhutan 1
CO - Colombia 1
DZ - Algeria 1
GY - Guiana 1
HN - Honduras 1
IE - Irlanda 1
JE - Jersey 1
KG - Kirghizistan 1
LS - Lesotho 1
MK - Macedonia 1
ML - Mali 1
MY - Malesia 1
MZ - Mozambico 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
TH - Thailandia 1
TN - Tunisia 1
Totale 1.757
Salva come PNG Salva come JPEG
Città #
San Jose 219
Singapore 132
Hong Kong 90
Shanghai 62
Ho Chi Minh City 44
Ashburn 40
Los Angeles 38
Tokyo 33
Beijing 32
Hanoi 26
New York 19
Buffalo 12
Dallas 11
Denver 11
Florence 11
Chicago 10
Frankfurt am Main 9
Mexico City 9
Munich 9
Poplar 9
Redondo Beach 9
Santa Clara 9
Atlanta 8
Johannesburg 7
Mumbai 6
Orem 6
São Paulo 6
Turku 6
Baghdad 5
Montreal 5
Warsaw 5
Chandigarh 4
Da Nang 4
Haiphong 4
Houston 4
Leicester 4
L’Aquila 4
Thái Bình 4
Thái Nguyên 4
Amsterdam 3
Bexley 3
Biên Hòa 3
Chennai 3
Dhaka 3
Helsinki 3
Kingston 3
Nashville 3
Phủ Lý 3
Porto Alegre 3
Quito 3
Quận Một 3
Rio de Janeiro 3
Stockholm 3
Tashkent 3
Addis Ababa 2
Almaty 2
Amman 2
Ankara 2
Aracaju 2
Bauru 2
Boardman 2
Brasília 2
Bridgetown 2
Brooklyn 2
Bắc Giang 2
Bắc Ninh 2
Can Tho 2
Cape Town 2
Carapicuíba 2
Colombo 2
Columbus 2
Dehradun 2
Des Moines 2
Doha 2
Erbil 2
Guayaquil 2
Ha Long 2
Hyderabad 2
Itapevi 2
Kansas City 2
Lucca 2
Maastricht 2
Miami 2
Milan 2
Mitry-Mory 2
Montevideo 2
Naples 2
Nha Trang 2
Palermo 2
Paris 2
Port of Spain 2
Qingdao 2
Ribeirão das Neves 2
Rome 2
Salt Lake City 2
Santiago 2
Santo André 2
Santo Domingo 2
Seattle 2
St Louis 2
Totale 1.067
Salva come PNG Salva come JPEG
Nome #
Functional recovery of islet β cells in human type 2 diabetes: Transcriptome signatures unveil therapeutic approaches 101
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals 80
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease 67
Performance of non-invasive tests for liver fibrosis resolution after bariatric surgery 67
HNF1A Deficiency Leads to Perturbed Glucagon Secretion in Humans 65
Genetic Modulation of HNF1A Activity via SGLT2 Deficiency Leads to Transient Intermittent Hyperglycemia: Consequences for HNF1A-MODY 59
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis 58
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD 58
Impact of therapeutic doses of prednisolone and other glucocorticoids on insulin secretion from human islets 57
Not all fats are created equal: adipose vs. ectopic fat, implication in cardiometabolic diseases 57
Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms 56
Low-dose treatment with sulfonylureas improves hyperglucagonemia after a glucose challenge in HNF1A-MODY individuals and Hnf1a-/- mice 55
Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions 50
Where to for precision treatment of HNF1A-MODY? 49
Analysis of heterogeneity of individual donor and islet glucagon responses to glucose stimulated hormone secretion and drug therapy 48
Analysis of Heterogeneity of Individual Donor and Islet Glucagon Responses to the SGLT2 Inhibitor Dapagliflozin 46
Aetiology and pathogenesis of HNF1A-MODY using human islets deficient of HNF1A and a new heterozygous mouse model (Hnf1aΔe4-10) of the human disease 45
The LIFE PERSUADED project approach on phthalates and bisphenol A biomonitoring in Italian mother-child pairs linking exposure and juvenile diseases 45
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease 44
Cytocompatibility evaluation of glycol-chitosan coated boron nitride nanotubes in human endothelial cells 43
Proglucagon-Derived Peptides Expression and Secretion in Rat Insulinoma INS-1 Cells 39
The role of the glucagon‐FGF21 axis in improving beta cell function during glucose intolerance and SGLT2 inhibition 39
SGLT2 inhibition and glucagon secretion in humans 38
The GLP1R Agonist Liraglutide Reduces Hyperglucagonemia Induced by the SGLT2 Inhibitor Dapagliflozin via Somatostatin Release 37
The central vs peripheral mediated effects of liraglutide enhancement on insulin secretion is dependent on the stage of diabetes 36
In non obese NAFLD increased plasma saturated fatty acids and insulin resistance are metabolic signatures of severity of liver disease 36
ADIPOSE TISSUE INSULIN RESISTANCE IS ASSOCIATED WITH MACROPHAGE ACTIVATION IN NON-DIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 33
Recombinant PSP/reg treatment improves beta cell function in islets isolated from glucose intolerant and type 2 diabetic donors 32
Impact of glucocorticoids on islet function: role of SRD5A1 as a modulator of glucocorticoids bioavailability 32
Metabolic effects of sodium-glucose-co-transporter-4 (SGLT4) inhibition: from mouse studies to clinical translation 32
Heterozygous HNF1A-MODY mice exhibit hyperglucagonemia preceding insulin secretory defects 29
Correction to: Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease: Steatohepatitis/Metabolic Liver Disease (Hepatology, (2016), 63, 1, (107-116), 10.1002/hep.28287) 28
Standardized dynamic glucose testing reveals donor-dependent heterogeneity in human islet function 27
Inter-Individual Heterogeneity of SGLT2 Expression and Function in Human Pancreatic Islets 27
LIPIDOMICS REVEALS THAT LOW PLASMA UNSATURATED TO SATURATED FAT RATIOS ARE BIOMARKERS OF NAFLD AND LIVER DAMAGE 27
Author Correction: Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD (Scientific Reports, (2017), 7, 1, (12200), 10.1038/s41598-017-11744-6) 24
DEREGULATION OF DE NOVO LIPOGENESIS CAN BE ASSOCIATED WITH LIVER DAMAGE IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE 21
ANGIOPOIETIN-LIKE4 IS ASSOCIATED WITH LIPID METABOLISM AND SEVERE FIBROSIS IN NON-DIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 21
Subjects with non alcoholic fatty liver disease (NAFLD) display increased visceral and pancreatic fat associated with worse metabolic profile 20
The GLP1R agonist liraglutide inhibits hyperglucagonaemia induced by the SGLT2 inhibitor dapagliflozin 19
GUT-LIVER AXIS DERANGEMENT DUE TO LACK OF INFLAMMASOME ACTIVITY LEADS TO VISCERAL OBESITY AND NASH DEVELOPMENT 19
Adverse impact of visceral fat on lipid and metabolic profile in fatty liver disease 16
LIVER DAMAGE CAN BE ASSOCIATED WITH DEREGULATION OF THE DE NOVO LIPOGENESIS PATHWAY IN SUBJECTS WITH NON ALCOHOLIC FATTY LIVER DISEASE 14
The Central-Versus Peripheral-Mediated Effects of Liraglutide Enhancement on Insulin Secretion is Dependent on the Stage of Diabetes 14
Gut-liver axis derangement due to lack of inflammasome activity leads to visceral obesity and nash development 11
NKX6.1 mRNA copy number is an actionable biomarker associated with islet function and clinical outcomes after islet transplantation 2
Totale 1.823
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.839
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.839
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025438 0 0 0 0 0 0 0 116 31 42 49 200
2025/20261.375 19 122 54 191 219 102 140 122 111 94 179 22
2026/202710 10 0 0 0 0 0 0 0 0 0 0 0
Totale 1.823